One of the salient lessons to come out of developmental biology over
the last two decades is that the mechanisms that control invertebrate development are
conserved to an extraordinary extent, from fruit flies to humans. This
lesson was put to the test in 1992 when researchers from Harvard, Columbia, Johns Hopkins,
the University of California at San Francisco, and Oxford set out to find the mammalian
equivalents of the hedgehog gene known to play an important role in pattern
formation in the developing fruit fly. The result, within the course of a year, was the
discovery of three new mammalian genes--known as sonic, indian, and desert
hedgehog--and the realization that the proteins they coded for could account for a
significant fraction of all the developmental interactions known to occur in the
vertebrate embryo.

"The hedgehog protein provides a
striking case in which a complex group of neurons that eventually function together are
all induced by the same signaling molecule, just by its acting at different
concentrations," says Thomas M. Jessell of the Howard Hughes Medical
Institute. "Its a very economical way of generating cell diversity." |
Among the major players in this developmental watershed was Thomas
M. Jessell, a Howard Hughes Medical Institute investigator at Columbia University College
of Physicians and Surgeons, New York, whose work helped elucidate the role sonic
hedgehog plays in the development and differentiation of the spinal cord and nervous
system. Jessell's remarkable influence in developmental biology is evidenced by a steady
and methodical production of high-impact papers, including two dozen in the past decade
with over 100 citations each, and six that have each been cited over 300 times. Along with
Andrew MacMahon, Douglas A. Melton, and Cliff Tabin of Harvard, Jessell is also one of the
founders of Ontogeny, Inc., a high-profile Cambridge, Massachusetts, biotech company that
aims at using the approaches of developmental biology to come up with new treatments for
diseases ranging from diabetes to Parkinson's.
Jessell, 47, received his undergraduate education at the University of
London, and went on to get a master's at London Hospital. In 1977, he earned his Ph.D. in
neuropharmacology from Cambridge University and in 1981, after three years of fellowships,
became an assistant professor of neurobiology at Harvard Medical School. In 1985 Jessell
moved to Columbia University College of Physicians and Surgeons, where he also became an
Investigator at the Howard Hughes Medical Institute. Since 1989, Jessell has been
professor in the Department of Biochemistry and Molecular Biophysics, at the Center for
Neurobiology and Behavior at Columbia.
From his office at Columbia, Jessell spoke to Science Watch correspondent Gary
Taubes.
: How would you describe the overall aim of your
laboratory?
Jessell: Our interest is in understanding how the nervous system
functions--specifically, how different cell types in the nervous system actually become
different. One basic problem is simply identifying these different cell types. At the very
early stages of development, its impossible to recognize a motor neuron or a sensory
neuron by their characteristic adult appearance. So we need to have an independent method
of distinguishing different classes of cells. This is where transcription factor biology
becomes very important, since the major molecular distinctions that exist between
different classes of neurons can be recognized by their different expression of specific
sets of transcription factors. So we can generate, for example, antibodies against these
proteins. Then, at very early stages of development--just as the earliest precursor of the
nervous system, the neural plate, is beginning to form the neural tube and the spinal
cord--we can start to recognize molecular differences between different cell types. That
is a key step in even defining an assay to identify the factors that control these
distinctions in cell identity.
: Can you explain what you mean by transcription factor
biology?
Jessell: The whole problem of developmental biology is how to turn specific sets
of genes on in specific cell types. The way to activate gene expression is through
transcription factors--the proteins that bind DNA and then lead to activation of target
genes. Over the last decade, from thousands of different labs, there has been an explosion
of information on different classes of transcription factors.
A breakthrough from our point of view was the observation than when one cell
expresses a particular protein and its neighbor doesn't, it gives you a molecular handle
to ask questions about how a given pattern of cell types is generated. Weve spent a
lot of time mapping the early expression of different classes of transcription factor. In
particular, weve been focusing on the spinal cord, and we can now do a rather good
job of accounting for each of the developmental stages, proceeding from a uniform group of
precursor cells in the neural plate, where all the cells are the same, to the point
halfway through nervous-system development where you have 20 different cell types.
: How do you find out when those transcription factors are turned on
and exactly what they do?
Jessell: One type of experiment, for instance, is to take a piece of
neural tissue at a time before it's been exposed to any environmental factors. You then
examine the fate of those cells under that default program, so to speak. The next step is
to add a potential source of an inductive signal and show that the program is changed--the
cells become something else. That extrinsic signal might turn out to be, for example,
hedgehog. An extrinsic signal is a protein that is excreted by one cell and which
influences or changes the fate of a neighboring cell. That's a process of cell-cell
communication. It changes the cells fate by turning one transcription factor on and
turning another one off. This experimental method uses transcription factors as sort of
molecular beacons to assay the existence of a diffusible or a cell-cell signal.
: The big breakthrough in your field was the discovery of the
hedgehog genes in mammals. How has that work been developed?
Jessell: It turns out that there are three hedgehog genes in higher
vertebrates, in mammals. Different groups cloned different hedgehogs early on.
They're all interesting, but the one that is the most interesting to us is a gene that
Cliff Tabin at Harvard eventually named sonic hedgehog. It turns out to be
expressed in precisely those cells in the limb bud that have the limb-patterning activity.
And it turns out to be expressed in just those cells under the spinal cord, in the
notochord and later in the floorplate, that have the spinal-cord-patterning activity,
which is what we were looking for.
By now, many papers have established the function and the necessity of
hedgehog in these signaling processes. In the context of the spinal cord, one of the
surprising things to emerge is that, at least in the ventral half of the spinal cord,
which generates many different cell types, hedgehog is responsible for the generation of
each of those cell types. It does this by acting at different concentration thresholds to
establish different cell fates.
: Different concentration thresholds?
Jessell: There is now evidence that two-fold differences in the concentration of
sonic hedgehog proteins to which a cell is exposed produce very dramatic changes in the
eventual fate of that cell. So we can do in vitro assays where we can essentially dial in
the concentration of hedgehog and generate a predictable cell type at each concentration.
There are many precedents for this, both in Drosophila and in vertebrate
development. The hedgehog example, however, provides a particularly striking case, where a
complex group of neurons that eventually function together--motor neurons and different
types of interneurons--are all induced by the same signaling molecule, just by its acting
at different concentrations. Its a very economical way of generating cell diversity
from one signaling molecule.
: How do the other two hedgehog genes fit into the developmental
picture?
Jessell: Desert and indian? They're expressed in different places
in the body, but to a large extent it appears that each of the proteins can substitute for
one another. Basically the general property of all three proteins is the ability to be
provided by one cell type and influence or change the fate of a surrounding cell type. And
you use these proteins repeatedly during development to control the development of many,
many different tissues. Clearly, hedgehogs are not the only proteins. And there are many
other classes of inducing molecules. Hedgehogs turn out to be one of the major families,
and they have unmistakably important roles in many different systems.
: The company that you helped found, Ontogeny, was started shortly
after the discovery of the hedgehog genes. What was the basis for its founding?
Jessell: The true impetus was primarily Doug Melton and Andy MacMahon at
Harvard. Cliff Tabin came in slightly later. We were all working on different
developmental systems. Doug was working on very early stages of mesoderm formation using
the frog as a system. Andy was working on the kidney and nervous system, while I was
working on the nervous system. But because of all the molecular genetics that had become
available, it became clear that one could think about developmental biology as a rather
unified field, and that the central role of inductive factors was inescapable. And, given
that there was a relatively restricted set of induction factors, it seemed that there must
be some application of those factors other than just basic scientific interest. continued
Science
Watch®, September/October 1998, Vol. 9, No. 5
Citing URL: http://www.sciencewatch.com/sept-oct/science-watch_sept-oct98_page3.htm |
Search
| September/October 1998 Index | Archives
| Contact
| Home
|